With Months to Live, Immunotherapy Gives Patient with Esophageal Cancer More Time
For John Joslyn, a patient with stage 4 esophageal cancer, traditional treatment methods weren’t working. With standard chemotherapy, it was estimated he may have had six months to live and he needed ...